BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ozaki K, Hayashi H, Ikuta Y, Masuda T, Akaboshi S, Ogata K, Matumoto K, Ogawa K, Kamio T, Baba H, Takamori H. Conversion surgery for initially unresectable pancreatic ductal adenocarcinoma with synchronous liver metastasis after treatment with FOLFIRINOX. Clin J Gastroenterol 2019;12:603-8. [PMID: 30993652 DOI: 10.1007/s12328-019-00965-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kato H, Horiguchi A, Ito M, Asano Y, Arakawa S. Essential updates 2019/2020: Multimodal treatment of localized pancreatic adenocarcinoma: Current topics and updates in survival outcomes and prognostic factors. Ann Gastroenterol Surg 2021;5:132-51. [PMID: 33860134 DOI: 10.1002/ags3.12427] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Shelemey PT, Amaro CP, Ng D, Falck V, Tam VC. Metastatic pancreatic cancer with complete response to FOLFIRINOX treatment. BMJ Case Rep 2021;14:e238395. [PMID: 34031062 DOI: 10.1136/bcr-2020-238395] [Reference Citation Analysis]
3 Takematsu T, Hayashi H, Higashi T, Yamao T, Uemura N, Matsumura K, Takeyama H, Yamamura K, Imai K, Yamashita YI, Baba H. Successful Treatment for the Recurrent Liver Metastases of the Pancreatic Cancer by Multimodality Therapy. Pancreas 2020;49:e75-6. [PMID: 32833952 DOI: 10.1097/MPA.0000000000001622] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]